TY - JOUR
T1 - Characterization of prolidase I and II from erythrocytes of a control, a patient with prolidase deficiency and her mother
AU - Ohhashi, Toshitaka
AU - Oono, Takashi
AU - Arata, Jiro
AU - Sugahara, Kazunobu
AU - Kodama, Hiroyuki
PY - 1990/1/31
Y1 - 1990/1/31
N2 - Prolidase I (EC 3.4.13.9) was purified to homogeneity from the erythrocytes of a normal human (control) and the patient's mother, and prolidase II from erythrocytes of a control and the patient's mother, and prolidase from the patient's erythrocytes was also highly purified. The various properties of the patient's prolidase were compared to those of prolidase from a control and the patient's mother. Prolidase I from a control and the patient's mother had a molecular weight of about 112,000, and was composed of two subunits with an identical molecular weight of 56,000. The Km values for Gly-Pro of the control's and the patient's mother's prolidase I were 2.90 ± 0.22 and 2.88 ± 0.27 mM, but the Vmax values for Gly-Pro of the mother's enzyme was reduced about 30% compared to that of control enzymes (mother: 6.02 units/mg protein, control: 22.21 units/mg protein). Isoionic points of these enzymes by chromatofocusing were pH 4.6 $ ̃4.7. Prolidase II from the control and the patient's mother, and the patient's prolidase had a molecular weight of about 185,000, and was composed of two subunits with an identical molecular weight of 95,000. The Km and Vmax values for various substrates of prolidase II from a control and the patient's mother, and the patient's prolidase were almost the same.
AB - Prolidase I (EC 3.4.13.9) was purified to homogeneity from the erythrocytes of a normal human (control) and the patient's mother, and prolidase II from erythrocytes of a control and the patient's mother, and prolidase from the patient's erythrocytes was also highly purified. The various properties of the patient's prolidase were compared to those of prolidase from a control and the patient's mother. Prolidase I from a control and the patient's mother had a molecular weight of about 112,000, and was composed of two subunits with an identical molecular weight of 56,000. The Km values for Gly-Pro of the control's and the patient's mother's prolidase I were 2.90 ± 0.22 and 2.88 ± 0.27 mM, but the Vmax values for Gly-Pro of the mother's enzyme was reduced about 30% compared to that of control enzymes (mother: 6.02 units/mg protein, control: 22.21 units/mg protein). Isoionic points of these enzymes by chromatofocusing were pH 4.6 $ ̃4.7. Prolidase II from the control and the patient's mother, and the patient's prolidase had a molecular weight of about 185,000, and was composed of two subunits with an identical molecular weight of 95,000. The Km and Vmax values for various substrates of prolidase II from a control and the patient's mother, and the patient's prolidase were almost the same.
KW - Erythrocyte
KW - Prolidase
KW - Prolidase deficiency
UR - http://www.scopus.com/inward/record.url?scp=0025058744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025058744&partnerID=8YFLogxK
U2 - 10.1016/0009-8981(90)90256-R
DO - 10.1016/0009-8981(90)90256-R
M3 - Article
C2 - 2317925
AN - SCOPUS:0025058744
SN - 0009-8981
VL - 187
SP - 1
EP - 9
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 1
ER -